| 34βE12 | High-molecular weight cytokeratin antibody (Clone 34βE12) |
| AE1/AE3 | Pan-cytokeratin antibody cocktail AE1/AE3 |
| ANOVA | Analysis of variance |
| AZ | Arizona |
| CATs | Cutaneous Adnexal Tumours |
| CD117 | Cluster of differentiation 117 (c-KIT) |
| CI | Confidence interval |
| CK7 | Cytokeratin 7 |
| COVID-19 | Coronavirus disease 2019 |
| CTK | Cytokeratin |
| DAB | 3,3′-Diaminobenzidine |
| EMA | Epithelial membrane antigen |
| ER | Estrogenic receptor |
| H&E | Haematoxylin&eosin |
| HMW | High-molecular weight |
| HPF | High-power field |
| IHC | Immunohistochemistry |
| IQR | Interquartile range |
| Ki-67 | Ki-67 proliferation index |
| MSO | Microsoft office |
| NOS | Not otherwise specified |
| PRAME | Preferentially expressed antigen in melanoma |
| Q1 | First quartile |
| Q3 | Third quartile |
| Q-Q Plot | Quantile–quantile plot |
| SD | Standard deviation |
| SOX10 | SRY-box transcription factor 10 |
| USA | United States of America |
| WHO | World Health Organization |